Latest filing published 23 Apr 2026 for Axsome Therapeutics, Inc., €453k.
Filing timeline
BuySaleInsider track record
Ari Maizel: trading record in brief
Ari Maizel discloses dealings in Axsome Therapeutics, Inc. to SEC (Form 4). We count 4 filings; the first trade dates from 21 January 2026 and the latest from 22 April 2026.
Sales make up the whole of the open-market record (2 sales, €2.3M). The rest of the record consists of 2 option exercises.
The record was last updated on 23 April 2026 with an option exercise (€453k) in Axsome Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ari Maizel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares@ US$70.730.0040% mcap21.8% of flowCommon StockSEC:0001193125-26-174415:0
- 7,500 shares@ US$182.420.010% mcap56.3% of flowCommon StockSEC:0001193125-26-174415:1
- 7,500 shares@ US$184.4436.3% of flowCommon StockSEC:0001193125-26-021377:1
- 7,500 shares@ US$70.7321.8% of flowCommon StockSEC:0001193125-26-021377:0
4 of 4 declarations
